Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business Development and Marketing, making him responsible for all of Aptuit's sales and marketing activities.
read more
CPhI Worldwide, organised by UBM Live, has announced its full line up of confirmed expert industry panel members for 2014, building on the huge success of the CPhI annual report launched at CPhI Worldwide in October 2013.
read more
SGS Life Science Services, the leading pharmaceutical analytical and bioanalytical contract solutions provider, today announced that is to expand its Shanghai, China, cGMP chemistry and microbiology laboratories to 2000 square meter by Q2 2015 and ...
read more
Hovione today announced that its API plant in Cork, Ireland has successfully passed a pre-approval inspection by the US Food and Drug Administration (FDA).
read more
Tuesday, October 07, 2014
The Board of Consort Medical plc, today announced that it has agreed terms to acquire the entire issued and to be issued share capital of Aesica Pharmaceuticals Limited for £230 million. The closing of the transaction, which is expected to occur in ...
read more
Dedicated temperature and humidity controlled labelling suites go live in USA and Europe as business from biosimilars and biologics clinical studies expands
read more
Almac are pleased to announce the launch of their novel “Direct to Patient” shipping service for clinical trials recognising the shift in market trends to introduce as many efficiencies as possible into the management of clinical trials and the ...
read more
Wednesday, November 12, 2014
DPT Laboratories, a Contract Development and Manufacturing Organization (CDMO) specializing in semi-solid and liquid dosage forms, announces the implementation of a [2]high-speed bottle filling center at its San Antonio location.
read more
Friday, November 14, 2014
CPhI Worldwide, organised by UBM Live, celebrates the closing of its most successful show to date with pre-audit figures estimating more than 36,000+ attendees and 2,500 exhibitors. Held this year in Paris, the show hosted senior-level decision ...
read more
Wednesday, December 03, 2014
Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion of an acquisition of pharmaceutical manufacturing capacity in Scotland, U.K. The ...
read more
Friday, December 05, 2014
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it had reached an exclusive development and licensing agreement...
read more
Monday, December 08, 2014
This award is recognition of both Pierre Fabre's expertise in dermatology, one of its development priorities, and of its ability to form public-private partnerships, such as that established with the University of Bordeaux.
read more
Tuesday, December 09, 2014
Today ZoBio (Leiden, The Netherlands) and Domainex Ltd. (Cambridge, UK) announce a collaboration with FORMA Therapeutics (Watertown, MA, USA) to provide NMR-based structural biology services for a substantial panel of FORMA drug targets.
read more
Thursday, December 11, 2014
Camargo Pharmaceutical Services, a leading drug development organization specializing in the 505(b)(2) approval pathway, joined inPack to present a seminar, “Non-Clinical and Clinical Study Design Factors in a Clinical Trial Protocol,” on Dec. 9 in ...
read more
Thursday, December 18, 2014
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX: AVXL), a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer’s disease, other diseases of the central nervous system (CNS) and various types of ...
read more